206 related articles for article (PubMed ID: 18471896)
1. Alloimmunity does not protect from challenge with the feline immunodeficiency virus.
Reggeti F; Bienzle D
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):152-62. PubMed ID: 18471896
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of a Texas feline immunodeficiency virus isolate: an emerging subtype of clade B.
Phadke AP; de la Concha-Bermejillo A; Wolf AM; Andersen PR; Baladandayuthapani V; Collisson EW
Vet Microbiol; 2006 Jun; 115(1-3):64-76. PubMed ID: 16574348
[TBL] [Abstract][Full Text] [Related]
3. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies.
Bull ME; Vahlenkamp TW; Dow JL; Collisson EW; Winslow BJ; Phadke AP; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 2004 May; 99(1-2):25-37. PubMed ID: 15113651
[TBL] [Abstract][Full Text] [Related]
5. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
[TBL] [Abstract][Full Text] [Related]
6. Shedding of feline immunodeficiency virus in semen of domestic cats during acute infection.
Jordan HL; Liang Y; Hudson LC; Tompkins WA
Am J Vet Res; 1999 Feb; 60(2):211-5. PubMed ID: 10048554
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
8. Low-dose interferon-alpha treatment for feline immunodeficiency virus infection.
Pedretti E; Passeri B; Amadori M; Isola P; Di Pede P; Telera A; Vescovini R; Quintavalla F; Pistello M
Vet Immunol Immunopathol; 2006 Feb; 109(3-4):245-54. PubMed ID: 16169599
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
[TBL] [Abstract][Full Text] [Related]
10. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
Pu R; Omori M; Okada S; Rine SL; Lewis BA; Lipton E; Yamamoto JK
Cell Immunol; 1999 Nov; 198(1):30-43. PubMed ID: 10612649
[TBL] [Abstract][Full Text] [Related]
11. FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.
Hofmann-Lehmann R; Holznagel E; Aubert A; Bauer-Pham K; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):115-25. PubMed ID: 7618251
[TBL] [Abstract][Full Text] [Related]
12. Exogenous glucocorticoids alter parameters of early feline immunodeficiency virus infection.
Barr MC; Huitron-Resendiz S; Selway DR; Henriksen SJ; Phillips TR
J Infect Dis; 2000 Feb; 181(2):576-86. PubMed ID: 10669341
[TBL] [Abstract][Full Text] [Related]
13. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
[TBL] [Abstract][Full Text] [Related]
14. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
Poulet H; Brunet S; Leroy V; Chappuis G
Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
[TBL] [Abstract][Full Text] [Related]
16. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
17. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
18. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
[TBL] [Abstract][Full Text] [Related]
19. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
20. Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.
Flynn JN; Cannon CA; Reid G; Rigby MA; Neil JC; Jarrett O
Immunology; 1995 Jun; 85(2):171-5. PubMed ID: 7543872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
